We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MLTX market cap is 2.89B. The company's latest EPS is USD -0.6900 and P/E is -65.70.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.77M | -16.7M | -12.93M | -13.19M | -12.98M |
| Net Income | 431k | -31.64M | -12.22M | -12.35M | -11.62M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -106k | -4.57M | -65.06M | -54.12M |
| Net Income | -91k | -4.54M | -64.51M | -44.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 88.59M | 76.84M | 66.8M | 506.62M | 500.22M |
| Total Liabilities | 6.02M | 8.08M | 7.69M | 7.51M | 10.58M |
| Total Equity | 82.57M | 68.77M | 59.11M | 499.11M | 489.64M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 116.63M | 115.84M | 76.84M | 526.54M |
| Total Liabilities | 4.15M | 7.9M | 8.08M | 13.05M |
| Total Equity | 5M | -7.06M | 68.77M | 513.49M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -44.3M | -55.89M | -9.02M | -21.18M | -30.43M |
| Investing | -42.24M | -32.34M | 19.65M | 32.33M | -142.05M |
| Financing | 119.69M | 119.69M | N/A | 451.29M | 451.29M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -317k | -611k | -55.89M | -42.78M |
| Investing | -115M | N/A | -32.34M | -25.19M |
| Financing | 116.65M | -58k | 119.69M | 479.7M |
| Market Cap | 2.89B |
| Price to Earnings Ratio | -65.70 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.42 |
| Price to Book Ratio | 5.64 |
| Dividend Yield | - |
| Shares Outstanding | 63.89M |
| Average Volume (1 week) | 287.57k |
| Average Volume (1 Month) | 336.81k |
| 52 Week Change | 116.66% |
| 52 Week High | 64.98 |
| 52 Week Low | 20.3501 |
| Spread (Intraday) | 3.65 (7.96%) |
| Company Name | MoonLake Immunotherapeutics |
| Address |
p.o. box 309 grand cayman 1104 |
| Website | https://moonlaketx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
